ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,856, issued on Aug. 11, was assigned to SDF BioPharma Inc (Scottsdale, Ariz.).
"Methods for reducing elevated glucose levels" was invented by Gerald Swiss (Mill Valley, Calif.) and David Kiewlich (Mill Valley, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are human transgenic beta cells expressing fugetactic levels of CXCL12 to a subject in need thereof. Also described herein are beta cells comprising a transgene comprising a nucleic acid sequence encoding CXCL12."
The patent was filed on April 9, 2024, under Application No. 18/630,991.
*For further information, including images, charts and tables, please visit: http://pat...